|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.09.25 - 09:15
|
PanGenomic Healths Subsidiary Mindleap Health Selects Hong Kong for its Health AI Centre Operations (The Newswire)
|
|
|
Vancouver, British Columbia, Canada, September 23, 2025 – TheNewswire - PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA, FSE:LL30) is pleased to announce that its wholly-owned subsidiary, Mindleap Health Inc. (“Mindleap Health"), plans to establish its Health AI Centre operations in Hong Kong.
“Mindleap Health is developing a real-world evidence (“RWE”) platform for the Complementary & Alternative Medicine (“CAM”) market and key to this platform will be access to health datasets in Asia and AI models developed by researchers in Asia”, said Robert Nygren, Executive Chair of PanGenomic Health and President of its wholly-owned subsidiary Mindleap Health. “With the support of a strategic advisory firm based in Hong Kong, we will set up a Health AI Centre in the fourth quarter of this year that will include development, research and marketing resources to advance our Mindleap RWE platform for CAM.”
The Mindleap RWE platform will collect and...
|
|
|
|
|
|
|
22.09.25 - 09:06
|
ITM Power: Paukenschlag – RWE will mehr (Der Aktionaer)
|
|
|
Gute Nachrichten von ITM Power zum Start in die neue Handelswoche. Der deutsche Energie-Riese RWE will perspektivisch mehr Elektrolyse-Module von den Briten beziehen. Dafür reserviert das DAX-Unternehmen eine hohe Megawatt-Zahl an Leistung beim Wasserstoff-Spezialisten....
|
|
|
|
|
|
|
19.09.25 - 11:54
|
RWE Buy (DPA-AFX)
|
|
|
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für RWE auf "Buy" mit einem Kursziel von 42 Euro belassen. Das Joint Venture mit Apollo verschaffe dem Versorger finanziellen Spielraum, schrieb Andrew Fisher in einer am Freitag ......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
